FILE - Equipment used to test for perfluoroalkyl and polyfluoroalkyl substances, known collectively as PFAS, in drinking water is seen at Trident Laboratories in Holland, Mich., June 18, 2018. Drinking water from nearly half of U.S. faucets likely contains “forever chemicals” linked to kidney cancer and other health problems, according to a government study released Wednesday, July 5, 2023. (Cory Morse/The Grand Rapids Press via AP, File)
TRAVERSE CITY, Mich. (AP) — Drinking water from nearly half of U.S. faucets likely contains “forever chemicals” that may cause cancer and other health problems, according to a government study released Wednesday.
The synthetic compounds known collectively as PFAS are contaminating drinking water to varying extents in large cities and small towns — and in private wells and public systems, the U.S. Geological Survey said.
Researchers described the study as the first nationwide effort to test for PFAS in tap water from private sources in addition to regulated ones. It builds on previous scientific findings that the chemicals are widespread, showing up in consumer products as diverse as nonstick pans, food packaging and water-resistant clothing and making their way into water supplies.
Because the USGS is a scientific research agency, the report makes no policy recommendations. But the information “can be used to evaluate risk of exposure and inform decisions about whether or not you want to treat your drinking water, get it tested or get more information from your state" about the situation locally, said lead author Kelly Smalling, a research hydrologist.
The U.S. Environmental Protection Agency in March proposed the first federal drinking water limits on six forms of PFAS, or per- and polyfluorinated substances, which remain in the human body for years and don't degrade in the environment. A final decision is expected later this year or in 2024.
But the government hasn't prohibited companies using the chemicals from dumping them into public wastewater systems, said Scott Faber, a senior vice president of the Environmental Working Group, an advocacy organization.
“We should be treating this problem where it begins, instead of putting up a stoplight after the accident," he said. “We should be requiring polluters to treat their own wastes.”
Studies of lab animals have found potential links between PFAS chemicals and some cancers, including kidney and testicular, plus issues such as high blood pressure and low birth weight.
Federal and state programs typically measure exposure to pollutants such as PFAS at water treatment plants or groundwater wells that supply them, Smalling said. In contrast, the USGS report was based on samples from taps in 716 locations, including 447 that rely on public supplies and 269 using private wells.
The samples were taken between 2016 and 2021 in a range of locations — mostly residences but also a few schools and offices. They included protected lands such as national parks; residential and rural areas with no identified PFAS sources; and urban centers with industry or waste sites known to generate PFAS.
Most taps were sampled just once. Three were sampled multiple times over a three-month period, with results changing little, Smalling said.
Scientists tested for 32 PFAS compounds — most of the ones detectable through available methods. Thousands of others are believed to exist but can't be spotted with current technology, Smalling said.
The types found most often were PFBS, PFHxS and PFOA. Also making frequent appearances was PFOS, one of the most common nationwide.
Positive samples contained as many as nine varieties, although most were closer to two. The median concentration was around seven parts per trillion for all 32 PFAS types, although for PFOA and PFOS it was about four parts per trillion — the limit EPA has proposed for those two compounds.
The heaviest exposures were in cities and near potential sources of the compounds, particularly in the Eastern Seaboard; Great Lakes and Great Plains urban centers; and Central and Southern California. Many of the tests, mostly in rural areas, found no PFAS.
Based on the data, researchers estimated that at least one form of PFAS could be found in about 45% of tap water samples nationwide.
The study underscores that private well users should have their water tested for PFAS and consider installing filters, said Faber of the Environmental Working Group. Filters containing activated carbon or reverse osmosis membranes can remove the compounds.
The USGS study is “further evidence that PFAS is incredibly pervasive and folks who rely on private wells are particularly vulnerable to the harms caused by these chemicals,” Faber said.
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
The boys discuss President Biden's plans to send out free rapid tests as the testing supply chain starts to buckle ahead of the holidays. Also, why aren't Americans having more babies, and The Matrix returns.
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
